130 results on '"Máiz, Luis"'
Search Results
2. Aerosolized ampicillin in a patient with chronic lung infection
3. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
4. RIBRON: The Spanish online bronchiectasis registry. Characterization of the first 1912 patients
5. RIBRON: el registro español informatizado de bronquiectasias. Caracterización de los primeros 1.912 pacientes
6. Bronchiectasis: A Complex, Heterogeneous Disease
7. Las bronquiectasias: una enfermedad compleja y heterogénea
8. Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP”
9. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience
10. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries
11. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults
12. Spanish Guidelines on Treatment of Bronchiectasis in Adults
13. Normativa sobre el tratamiento de las bronquiectasias en el adulto
14. Normativa sobre la valoración y el diagnóstico de las bronquiectasias en el adulto
15. Prediction of the intestinal resistome by a three-dimensional structure-based method
16. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study
17. The role of precision medicine in bronchiectasis: emerging data and clinical implications
18. Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry
19. Etiología de las bronquiectasias en una cohorte de 2.047 pacientes. Análisis del registro histórico español
20. Bronchopulmonary infection–colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
21. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
22. Consenso español para la prevención y el tratamiento de la infección bronquial por Pseudomonas aeruginosa en el paciente con fibrosis quística
23. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study
24. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis
25. Cough in Children
26. Tos en el niño
27. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes
28. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives
29. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study
30. Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study
31. Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
32. Prevalence and Factors Associated with Isolation of Aspergillus and Candida from Sputum in Patients with Non-Cystic Fibrosis Bronchiectasis
33. Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases
34. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial
35. Fe de errores de Normativa sobre la valoración y el diagnóstico de las bronquiectasias en el adulto [Arch Bronconeumol. 2018;54(2):79–87]
36. ¿Qué supuso el consenso español para el tratamiento de la infección por Pseudomonas aeruginosa en pacientes con fibrosis quística en la infección pulmonar inicial?
37. Prediction of the intestinal resistome by a three-dimensional structure-based method
38. Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis
39. Fungi in Bronchiectasis: A Concise Review
40. Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients
41. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period
42. Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis
43. ¿Qué supuso el consenso español para el tratamiento de la infección por Pseudomonas aeruginosaen pacientes con fibrosis quística en la infección pulmonar inicial?
44. Annual direct medical costs of bronchiectasis treatment
45. Bronchopulmonary infection–colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
46. Management of pulmonary exacerbations in cystic fibrosis: still an unmet medical need in clinical practice
47. Subcutaneous implant with etonogestrel (Implanon®) for catamenial exacerbations in a patient with cystic fibrosis: a case report
48. Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureusEpidemic Clone Isolated from Patients with Cystic Fibrosis
49. Subcutaneous implant with etonogestrel (Implanon®) for catamenial exacerbations in a patient with cystic fibrosis: a case report.
50. Aerosolized Ampicillin in a Patient With Recurrent Respiratory Infections.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.